Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

FIJI: Tuberculosis A Threat to Fiji


Fiji Times (Suva) (11.14.12)

The Journal of Public Health report for Fiji’s Ministry of Health, which was released in 2012, described TB as still constituting a major threat to the country’s population. According to the Ministry of Health Project officer for TB, Asenaca Mataika, the most recent data from the World Health Organization Global Report 2011 showed that Fiji had an incidence rate of 27 per 100,000 people and a prevalence rate of 40 per 100,000 people. Mataika stated that in 2010, there were 191 active TB cases recorded by the national program, and in 2011, there were 213. Of the 213 cases in 2011, 24 percent were in the Central and Eastern Divisions, 41 in the Western Division, and 17 in the Northern Division. People with low socioeconomic status, poor housing, and unhealthy lifestyles who live mainly in semi-urban and densely populated areas were the most commonly affected by TB. Also, those in the most productive age group—between ages 15 and 55 years—were also heavily affected. Males were more affected than females, and 7 to 11 percent of the total cases were children under age 15 years. Mataika said that the treatment success rate of new smear-positive TB cases in 2010 was 67 percent. Of the 33 percent of patients that were not successfully treated, six percent had died, 24 percent defaulted on treatment, and 3 percent were lost to follow-up. Mataika commented that other co-morbid conditions such as TB/HIV co-infection and TB combined with diabetes mellitus were challenges that the National TB Program needed to address to fully control TB. She explained that persons with symptoms of TB should be investigated and that any TB suspect could be referred to the DOTS (Directly Observed Treatment Short course) centers at Tamavua, Lautoka, and Labasa hospitals.


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in November 14, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.